tm logo

Monitor this mark

View On USPTO

ANQLAR
Live/Pending
FIFTH EXTENSION - GRANTED

granted

on 28 Jun 2024

Last Applicant/ Owned by

Virpax Pharmaceuticals Inc.

1055 Westlake Drive, Suite 300

Berwyn

PA

19312

Serial Number

90555318 filed on 02th Mar 2021

Registration Number

N/A

Correspondent Address

G Kenneth Smith

G Kenneth Smith

BETHLEHEM, PA 18015

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ANQLAR

Amphiphilic carbohydrate formulation for use in the prevention or treatment of a viral infection

Classification Information

Class [005]
Pharmaceutical Products

Amphiphilic carbohydrate formulation for use in the prevention or treatment of a viral infection

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 90555318

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
28th Jun 2024SOU EXTENSION 5 FILED
28th Jun 2024SOU EXTENSION 5 GRANTED
28th Jun 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
28th Jun 2024SOU TEAS EXTENSION RECEIVED
23rd Feb 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
22nd Feb 2024SOU EXTENSION 4 GRANTED
30th Jan 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
30th Jan 2024PETITION TO REVIVE-GRANTED
30th Jan 2024TEAS PETITION TO REVIVE RECEIVED
30th Jan 2024NOTICE OF REVIVAL - E-MAILED